Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN68019845
ISRCTN68019845
Completed
Not Applicable

Dual antiplatelet therapy in the acute phase following stroke and transient ischaemic attack (TIA): which is the best regimen?

St George's Heathcare NHS Trust (UK)0 sites60 target enrollmentMay 30, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
St George's Heathcare NHS Trust (UK)
Enrollment
60
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 30, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
St George's Heathcare NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Women or men aged greater than 18 years
  • •2\. Patients with greater than or equal to 50% carotid artery stenosis
  • •3\. Symptoms of TIA or stroke within the last month
  • •4\. Baseline magnetic resonance imaging (MRI) or computed tomography (CT) imaging has been performed
  • •5\. Consented to take part in the study

Exclusion Criteria

  • •1\. Currently taking antiplatelet/antithrombotic medication other than aspirin (although low does prophylactic subcutaneous heparin for deep vein thrombosis \[DVT] prophylaxis will be allowed)
  • •2\. Patients with prosthetic heart valves who have gaseous embolic signals
  • •3\. Where clopidogrel or dipyridamole is contra\-indicated
  • •4\. Carotid endarterectomy planned within the next month
  • •5\. Pregnant and lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Dual antiplatelet therapy in the acute phase following stroke and TIA; which is the best regimen?Symptomatic carotid artery stenosisMedDRA version: 9.1 Level: LLT Classification code 10007687 Term: Carotid artery stenosis
EUCTR2007-002681-34-GBSt Georges Healthcare NHS Trust
Completed
Not Applicable
oborI dual antiplatelet therapy as aPPropriate duratiON (NIPPON)Coronary Artery Disease
JPRN-UMIN000006698PO Associations for Establishment of Evidence in Interventions4,598
Active, not recruiting
Not Applicable
ACUTE-PRAS
JPRN-jRCTs031220079Fujimoto Shigeru200
Active, not recruiting
Phase 1
Single versus Dual Antiplatelet Therapy in patients with Incomplete Revascularization after Coronary artery bypass graft surgery
EUCTR2017-001754-33-ITIVERSITÀ CAMPUS BIO-MEDICO DI ROMA800
Completed
Phase 4
Duration of Dual Anti-Platelet Therapy (DUAL-ACS)Acute Coronary SyndromeCoronary Artery Disease
NCT03252249University of Edinburgh5,094